Regulation of inflammation- and angiogenesis-related gene expression in breast cancer cells and co-cultured macrophages

Anticancer Research

Volumn 28, Issue 4 B, 2008, Pages 2093-2099

  Burnett, Giselle T ^a   Weathersby, Demse C ^a,b   Taylor, Tiffany E ^a   Bremner, Theodore A ^a,c  

^a HOWARD UNIVERSITY   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c HOWARD UNIVERSITY CANCER CENTER   (United States)

Author keywords

Angiogenesis; Aspirin; IL 10; Inflammation; MIF; Tamoxifen

Indexed keywords

ACETYLSALICYLIC ACID; ANTINEOPLASTIC AGENT; INTERLEUKIN 10; MACROPHAGE MIGRATION INHIBITION FACTOR; TAMOXIFEN;

ANGIOGENESIS; ARTICLE; BREAST ADENOCARCINOMA; BREAST CANCER; CANCER CELL CULTURE; CELL INTERACTION; CONTROLLED STUDY; DOWN REGULATION; DRUG MECHANISM; GENE EXPRESSION; GENETIC ANALYSIS; HUMAN; HUMAN CELL; INFLAMMATION; MACROPHAGE ACTIVATION; PHENOTYPE; POLARIZATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR ASSOCIATED LEUKOCYTE; UPREGULATION; WESTERN BLOTTING;

ADENOCARCINOMA; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; BREAST NEOPLASMS; CELL LINE, TUMOR; COCULTURE TECHNIQUES; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INFLAMMATION; INTERLEUKIN-1BETA; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MACROPHAGES; NEOVASCULARIZATION, PATHOLOGIC; PTEN PHOSPHOHYDROLASE; RECOMBINANT PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, NEOPLASM; TAMOXIFEN; TUMOR SUPPRESSOR PROTEIN P53;

EID: 49049104178     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Guiducci C, Vicari AP, Sangaletti S, Trinchieri G and Colombo MP: Redirecting in vivo elicited tumor infiltrating macrophages and dendritic cells towards tumor rejection. Cancer Res 65: 3437-3446, 2005.
2. Gupta PB, Proia D, Cingoz O, Weremowicz J, Naber SP, Weinberg RA et al: Systemic stromal effects of estrogen promote the growth of estrogen receptor-negative cancers. Cancer Res 67: 2062-2071, 2007.
3. Condeelis J and Pollard JW: Macrophages: obligate partners for tumor cell migration, invasion, and metastasis. Cell 124: 263-267, 2006.
4. Cheng J, Huo D-H, Kuang D-M, Yang J, Zheng L and Zhuang S-M: Human macrophages promote the motility and invasiveness of osteopontin-knockdown tumor cells. Cancer Res 67: 5141-5147, 2007.
5. Lin EY and Pollard JW: Tumor-associated macrophages press the angiogenic switch in breast cancer. Cancer Res 67: 5064-5066, 2007.
6. Rauh MJ, Sly LM, Kalesnikoff J, Hughes MR, Cao LP, Lam V et al: The role of SHIPI in macrophage programming and activation. Biochem Soc Trans 32: 785-788, 2004.
7. Zhu P, Baek SH, Bourk EM, Ohgi KA, Garcia-Bassets I, Sanjo H et al: Macrophage/cancer cell interactions mediate hormone resistance by a nuclear receptor derepression pathway. Cell 124: 615-629, 2006.
8. Odegaard JI, Ricardo-Gonzalez RR, Goforth MH, Morel CR, Subramanian V, Mukundan L et al: Macrophage-specific PPARγ controls alternative activation and improves insulin resistance. Nature 447: 1116-1120, 2007.
9. Mukherjee S, Frolova N, Sadlonova A, Novak Z, Steg A, Page GP et al: Hedgehog signaling and response to cyclopamine differ in epithelial and stromal cells in benign breast and breast cancer. Cancer Biol Ther 5: 674-683, 2006.
10. Arcuri F, Cintorino M, Vatti R, Carducci A, Liberatori S and Paulesu L: Expression of macrophage migration inhibitory factor transcript and protein by first-trimester human trophoblasts. Biol Reprod 60: 1299-1303, 1999.
11. Bacher M, Meinhardt A, Lan HY, Mu W, Metz CN, Chesney JA et al: Migration inhibitory factor expression in experimentally induced endotoxemia. Am J Pathol 150: 235-246, 1997.
12. Calandra T and Roger, T: Macrophage migration inhibitory factor: a regulator of innate immunity. Nat Rev Immunol 3: 791-800, 2003.
13. Hudson JD, Shoaibi MA, Maestro R, Carnero A, Hannon GJ and Beach DH: A proinflammatory cytokine inhibits p53 tumor suppressor activity. J Exp Med 190: 1375-1382, 1999.
14. Mitchell RA, Liao H, Chesney J, Fingerle-Rowson G, Baugh J, David J et al: Macrophage migration inhibitory factor (MIF) sustains macrophage proinflammatory function by inhibiting p53: Regulatory role in the innate immune response. Proc Natl Acad Sci USA 99: 345-350, 2002.
15. Agarwal R, Whang DH, Alvero AB, Visintin I, Lai Y and Segal EA: Macrophage migration inhibitory factor expression in ovarian cancer. Am J Obstet Gynecol 196: 348.el-5, 2007.
16. Wilson JM, Coletta PL, Cuthbert RJ, Scott N, MacLennan K, Hawcroft G et al: Macrophage migration inhibitory factor promotes intestinal tumorigenesis. Gastroenterology 129: 1485-1503, 2005.
17. Hagemann T, Robinson SC, Thompson RG, Charles K, Kulbe H and Balkwill FR: Ovarian cancer cell-derived migration inhibitory factor enhances tumor growth, progression, and angiogenesis. Mol Cancer Ther 6: 1993-2002, 2007.
18. Baumann R, Casaulta C, Simon D, Conus S, Yousefi S and Simon H-U: Macrophage migration inhibitory factor delays apoptosis in neutrophils by inhibiting the mitochondria-dependent death pathway. FASEB J 17: 2221-2230, 2003.
19. Lue H, Thiele M, Franz J, Dahl E, Speckgens S, Leng L et al: Macrophage migration inhibitory factor (MIF) promotes cell survival by activation of the Akt pathway and role for CSN5/JAB1 in the control of autocrine MIF activity. Oncogene 26: 5046-5059, 2007.
20. Nguyen MT, Lue H, Kleemann R, Thiele M, Tolle G, Finkelmeier D et al: The cytokine macrophage migration inhibitory factor reduces pro-oxidative stress-induced apoptosis. J Immunol 170: 3337-3347, 2003.
21. Bernhagen J, Krohn R, Lue H, Gregory JL, Zernecke A, Koenen RR et al: MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment. Nat Med 13: 587-596, 2007.
22. Burger JA and Kipps TJ: CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment. Blood 107: 1761-1767, 2006.
23. Leng L, Metz CN, Fang Y, Xu J, Donnelly S, Baugh J et al: MIF signal transduction initiated by binding to CD74. J Exp Med 197: 1467-1476, 2003.
24. Shi X, Leng L, Wang T, Wang W, Du X, Li J et al: CD44 is the signaling component of the macrophage migration inhibitory factor-CD74 receptor complex. Immunity 25: 595-606, 2006.
25. Becker-Herman S, Arie G, Medvedovsky H, Kerem A and Shachar I: CD74 is a member of the regulated intramembrane proteolysis-processed protein family. Mol Biol Cell 16: 5061-5069, 2005.
26. Roger T, David J, Glauser MP and Calandra T: MIF regulates innate immune responses through modulation of Toll-like receptor 4. Nature 414: 920-924, 2001.
27. Roger T, Chanson A-L, Knaup-Reymond M and Calandra T: Macrophage migration inhibitory factor promotes innate immune responses by suppressing glucocorticoid-induced expression of mitogen-activated protein kinase phosphatase-1. Eur J Immunol 35: 3405-3413, 2005.
28. Aeberli D, Yang Y, Mansell A, Santos L, Leech M and Morand EF: Endogenous macrophage migration inhibitory factor modulates glucocorticoid sensitivity in macrophages via effects on MAP kinase phosphatase-1 and p38 MAP kinase. FEES Letters 580: 974-981, 2006.
29. Tang Y and Eng C: PTEN autoregulates its expression by stabilization of p53 in a phosphatase-independent manner. Cancer Res 66: 736-742, 2006.
30. Guadagni F, Ferroni P, Palmirotta R, Del Monte G, Formica, V and Roselli M: Non-steroidal anti-inflammatory drugs in cancer prevention and therapy. Anticancer Res 27: 3147-3162, 2007.
31. Hagemann T, Wilson J, Kuble H, Li NF, Leinster DA, Charles K et al: Macrophages induce invasiveness of epithelial cancer cells via NF-κB and JNK. J Immunol 175: 1197-1205, 2005.
32. Sugimoto K, Toyoshima H, Sakai R, Miyagawa K, Hagiwara K, Ishikawa F et al: Frequent mutations in the p53 gene in human myeloid leukemia cell lines. Blood 79: 2378-2383, 1992.
33. Bacher M, Schrader J, Thompson N, Kuschela K, Gemsa D, Waeber G et al: Up-regulation of macrophage migration inhibitory factor gene and protein expression in glial tumor cells during hypoxic and hypoglycemic stress indicates a critical role for angiogenesis in glioblastoma multiforme. Amer J Pathol 163: 11-17, 2003.
34. Wu J, Cunha FQ, Liew FY and Weiser WY: IL-1O inhibits the synthesis of migration inhibitory factor and migration inhibitory factor-mediated macrophage activation. J Immunol 151: 4325-4332, 1993.